GAMMA Investing LLC Has $11.05 Million Stock Position in Oracle Corporation $ORCL

GAMMA Investing LLC increased its stake in shares of Oracle Corporation (NYSE:ORCL) by 8.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,298 shares of the enterprise software provider’s stock after buying an additional 3,021 shares during the quarter. Oracle comprises approximately 0.6% of GAMMA Investing LLC’s investment portfolio, making the stock its 23rd biggest position. GAMMA Investing LLC’s holdings in Oracle were worth $11,052,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Swiss National Bank boosted its stake in shares of Oracle by 7.6% during the second quarter. Swiss National Bank now owns 5,093,200 shares of the enterprise software provider’s stock valued at $1,113,526,000 after purchasing an additional 360,000 shares in the last quarter. Private Wealth Asset Management LLC grew its position in shares of Oracle by 9.2% in the 2nd quarter. Private Wealth Asset Management LLC now owns 3,817 shares of the enterprise software provider’s stock valued at $835,000 after buying an additional 321 shares during the last quarter. Soltis Investment Advisors LLC grew its position in shares of Oracle by 4.8% in the 2nd quarter. Soltis Investment Advisors LLC now owns 32,937 shares of the enterprise software provider’s stock valued at $7,201,000 after buying an additional 1,515 shares during the last quarter. Cascade Investment Group Inc. acquired a new stake in shares of Oracle in the second quarter valued at about $239,000. Finally, Lockerman Financial Group Inc. bought a new position in shares of Oracle during the second quarter worth about $328,000. 42.44% of the stock is owned by institutional investors.

Oracle Price Performance

Shares of NYSE ORCL opened at $184.79 on Tuesday. The firm has a market capitalization of $526.80 billion, a P/E ratio of 34.73, a P/E/G ratio of 1.82 and a beta of 1.66. The firm’s 50-day moving average price is $243.44 and its 200-day moving average price is $242.09. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72.

Oracle (NYSE:ORCL) last issued its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 EPS for the quarter, beating the consensus estimate of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The company had revenue of $16.06 billion during the quarter, compared to the consensus estimate of $16.19 billion. During the same period last year, the business posted $1.47 EPS. The firm’s revenue for the quarter was up 14.2% compared to the same quarter last year. Equities research analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 23rd. Stockholders of record on Friday, January 9th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, January 9th. This represents a $2.00 annualized dividend and a dividend yield of 1.1%. Oracle’s payout ratio is currently 37.59%.

Insider Activity at Oracle

In other Oracle news, CEO Clayton M. Magouyrk sold 40,000 shares of the company’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $276.64, for a total transaction of $11,065,600.00. Following the transaction, the chief executive officer owned 154,030 shares in the company, valued at approximately $42,610,859.20. This represents a 20.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Maria Smith sold 5,000 shares of the firm’s stock in a transaction on Thursday, October 23rd. The shares were sold at an average price of $280.62, for a total transaction of $1,403,100.00. Following the completion of the transaction, the executive vice president directly owned 47,083 shares in the company, valued at $13,212,431.46. This trade represents a 9.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 155,190 shares of company stock valued at $45,279,001 over the last three months. 40.90% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ORCL has been the topic of several analyst reports. BNP Paribas set a $377.00 target price on Oracle in a report on Wednesday, September 10th. Baird R W raised shares of Oracle to a “strong-buy” rating in a research note on Wednesday, October 8th. BMO Capital Markets decreased their price objective on shares of Oracle from $355.00 to $270.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Rothschild & Co Redburn assumed coverage on shares of Oracle in a report on Thursday, September 25th. They issued a “sell” rating and a $175.00 target price on the stock. Finally, Royal Bank Of Canada decreased their price target on Oracle from $310.00 to $250.00 and set a “sector perform” rating for the company in a report on Thursday. Three research analysts have rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Oracle has an average rating of “Moderate Buy” and a consensus target price of $302.92.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.